SCHEMBL4768907

SCHEMBL4768907

CCn1cnc2c(=O)nc(Cc3cc(F)ccc3F)n(-c3ccc(F)cc3)c21

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.34
HPGD P15428 3/20 0.34
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
TSHR P16473 2/20 0.34
LMNA P02545 1/20 0.34
MAT2A P31153 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
CDK1 P06493 2/20 0.33
ROCK2 O75116 2/20 0.33
KDM4E B2RXH2 4/20 0.32
ALDH1A1 P00352 3/20 0.32
HSD17B10 Q99714 2/20 0.32
HTR6 P50406 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
RXFP1 Q9HBX9 1/20 0.32
BRD9 Q9H8M2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4772467 0.89 MAT2A (0.40) SMN1; SMN2HPGDNPC1RAB9ATSHR
SCHEMBL4776782 0.86 CDK1 (0.33) SMN1; SMN2HPGDNPC1RAB9ATSHR
SCHEMBL4529801 0.84 SMN1; SMN2 (0.39) SMN1; SMN2HPGDNPC1RAB9ATSHR
SCHEMBL4778102 0.83 MAPK1 (0.36) SMN1; SMN2NPC1RAB9ATSHRKDM4E
SCHEMBL4522510 0.80 GSR (0.40) SMN1; SMN2HPGDNPC1RAB9ATSHR
SCHEMBL4774078 0.79 MEN1 (0.38) SMN1; SMN2CDK1KDM4EALDH1A1MEN1
SCHEMBL4256906 0.78 BRD4 (0.40) CYP2C19
SCHEMBL4531589 0.78 HKDC1 (0.39) SMN1; SMN2HPGDNPC1RAB9ATSHR
SCHEMBL4357095 0.77 MAT2A (0.38) SMN1; SMN2HPGDNPC1RAB9ATSHR
SCHEMBL4518958 0.76 SMN1; SMN2 (0.43) SMN1; SMN2HPGDNPC1RAB9ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1881988-A1 2,3-SUBSTITUTED FUSED BICYCLIC PYRIMIDIN-4(3H)-ONES MODULATING THE FUNCTION OF THE VANILLOID-1 RECEPTOR (VR1) MERCK SHARP & DOHME LTD. (GB) 2008-01-30 EP disclosed
WO-2006122200-A1 2,3-SUBSTITUTED FUSED BICYCLIC PYRIMIDIN-4(3H)-ONES MODULATING THE FUNCTION OF THE VANILLOID-1 RECEPTOR (VR1) MERCK SHARP & DOHME LIMITED (GB) 2006-11-16 WO disclosed